Home / Intelligence / Scientific Publications / U.S. Prevalence & Mortality of Prader-Willi Syndrome: A Population-Based Study of Medical Claims
Prader-Willi syndrome (PWS) is a complex developmental genetic disorder associated with hypotonia, poor feeding in neonates, onset of hyperphagia in early childhood, and shorter overall life expectancy. Prior epidemiology studies of PWS have examined smaller populations, with limited research in a US population. The aim of this study was to provide a contemporary estimate of PWS prevalence and annual all-cause mortality in the US using a large administrative medical claims dataset.
Authors
Shawn McCandless, Marissa Suh, David Yin, Michael Yeh, Shawn Czado, Sina Aghsaei, Justin Li, Kevin Francis, Nandini Hadker, Diane Stafford
Journal
Journal of the Endocrine Society; Volume 4; Issue Supplement_1; April-May 2020
Related Intelligence
Webinars
RWD Expertise x Technology = Enhanced Patient Outcomes
March 27, 2025 | 12:00 – 12:45 PM ET
The addition of real-world data (RWD) to other data streams through technology allows the patient impact to be magnified many times. Combined with PMR, RWD can drive exceptional insights and accuracy in demand assessments, segmentation, message testing, market mapping and ATUs. Amplified with GenAI and solutions like Real Insights and RealWorldEDGE, the range of RWD-powered […]
Sign Up Now
Blog
Culture and Collaboration: Keys to Customer Engagement Success
We’re delighted to bring an external expert perspective to the “One Chapter Ahead” blog series and the important topic of culture and collaboration. Amy Saunders is a recognized customer experience global leader across life science verticals including pharma, med devices and consumer packaged goods (CPG) for companies such as J&J Consumer, W.L. Gore and Novartis. […]
Read More
Webinars
Virtual Demo | HTA Vision with GenAI
March 13, 2025 | 11:00 – 11:30 AM ET
Join Trinity Life Sciences for a virtual demo where value, access and pricing experts Max Hunt and Andreia Ribeiro will demonstrate Trinity HTA Vision, our cloud-based dashboard with GenAI capabilities. It is not enough to know what the health technology assessment (HTA) decisions are and when they are made—with the landscape continually evolving, analogues and future […]
Sign Up Now